LobbyingAmerican Laboratories Pharma lobbying by quarter
American Laboratories Pharma's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $95K. Its first report covers Q3 2025; the issues it reports most are Health Issues.
American Laboratories Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $95K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $80K | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $45K | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$175K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
Firms it paid
| Firm | ||
|---|---|---|
| First Principles Strategies | $175K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOSEPH ROBERT MURRAY | Republican Study Committee; Rep. Mark Meadows; Senator Ron Johnson | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/19for Q2 | First Principles Strategies | $50K |
| 06/11for Q1 | First Principles Strategies | $45K |
| 01/31for Q4 2025 | First Principles Strategies | Under $5,000 |
| 25/11/19for Q3 2025 | First Principles Strategies | $80K |
| 25/08/24for Q3 2025 | First Principles Strategies | Under $5,000 |